Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00244309Phase 3Completed
Phase 3, randomised trial of tamsulosin and dutasteride in urinary retention (4 arms), sponsored by Case Comprehensive Cancer Center. Primary endpoint: American Urological Association symptom score. Started Nov 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00244309.